LeMaitre Vascular, Inc. (FRA:LHU)

Market Cap	1.62B -24.1%
Revenue (ttm)	205.29M +13.1%
Net Income	45.46M +29.1%
EPS	1.98 +27.4%
Shares Out	n/a
PE Ratio	35.69
Forward PE	31.64
Dividend	0.71 (1.02%)
Ex-Dividend Date	Nov 20, 2025

Volume	n/a
Average Volume	n/a
Open	69.50
Previous Close	70.50
Day's Range	69.50 - 69.50
52-Week Range	67.50 - 98.50
Beta	n/a
RSI	41.16
Earnings Date	Feb 27, 2026

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheter...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1983
• Employees: 664
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LHU

Financial Performance

In 2024, LeMaitre Vascular's revenue was $219.86 million, an increase of 13.63% compared to the previous year's $193.48 million. Earnings were $44.04 million, an increase of 46.28%.

Financial numbers in USD